This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
For the HERO investigators, Drs. Martí-Fàbregas et al. report their results from the prospective, multicenter observational cohort that sought to estimate the long-term risk of intracranial hemorrhage (ICH) among patients aged >65 years with cardioembolic stroke and treated with an oral anticoagulant. Nearly 1,000 patients were followed over mean of 2 years. Ninety percent of patients had atrial fibrillation as the primary indication for anticoagulation, and two-thirds of patients were treated using warfarin. The annualized rate of ICH was 1%/yr—as has been previously reported—with a higher rate among patients with cerebral microhemorrhages (2.5%/yr with >1 microhemorrhage), with moderate/severe microvascular changes on MRI (2%/yr), and with both of these findings (3.8%/yr). Dr. Vilanilam and colleagues highlight a study limitation that included patients were not evaluated using identical MRI magnet strength (16% underwent 3T MRI) or MRI sequences (49% underwent SWI; 91% underwent GRE with or without SWI). The authors acknowledge that this could have affected their findings and stressed the uniformity of MRI magnet strength and consistency of sequences for future studies.
For the HERO investigators, Drs. Martí-Fàbregas et al. report their results from the prospective, multicenter observational cohort that sought to estimate the long-term risk of intracranial hemorrhage (ICH) among patients aged >65 years with cardioembolic stroke and treated with an oral anticoagulant. Nearly 1,000 patients were followed over mean of 2 years. Ninety percent of patients had atrial fibrillation as the primary indication for anticoagulation, and two-thirds of patients were treated using warfarin. The annualized rate of ICH was 1%/yr—as has been previously reported—with a higher rate among patients with cerebral microhemorrhages (2.5%/yr with >1 microhemorrhage), with moderate/severe microvascular changes on MRI (2%/yr), and with both of these findings (3.8%/yr). Dr. Vilanilam and colleagues highlight a study limitation that included patients were not evaluated using identical MRI magnet strength (16% underwent 3T MRI) or MRI sequences (49% underwent SWI; 91% underwent GRE with or without SWI). The authors acknowledge that this could have affected their findings and stressed the uniformity of MRI magnet strength and consistency of sequences for future studies.
Footnotes
Author disclosures are available upon request (journal{at}neurology.org).
- Received March 9, 2020.
- Accepted in final form March 6, 2020.
- © 2020 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Disputes & Debates: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.